▁Ad 7.44921875
van 3.8359375
c 2.029296875
ements 0.027130126953125
▁in 0.165283203125
▁the 2.59765625
▁treatment 2.9296875
▁of 0.10015869140625
▁mel 5.390625
an 0.0193939208984375
oma 0.019744873046875
▁have 1.767578125
▁greatly 4.3359375
▁improved 0.54931640625
▁the 1.2578125
▁potential 6.78515625
▁for 0.272705078125
▁long 1.5234375
- 0.10247802734375
term 0.0166778564453125
▁rem 3.59765625
ission 0.03759765625
, 2.16015625
▁particularly 3.759765625
▁with 1.7216796875
▁the 0.63330078125
▁use 1.80078125
▁of 0.0052947998046875
▁imm 1.4296875
une 1.4443359375
▁check 0.27099609375
point 0.013946533203125
▁in 0.1334228515625
hib 0.00031447410583496094
itors 0.075927734375
▁and 3.115234375
▁adj 4.26953125
uv 0.04217529296875
ant 0.0261993408203125
▁ther 0.5966796875
ap 1.2685546875
ies 0.003631591796875
. 0.264404296875
▁These 3.103515625
▁treat 2.7421875
ments 0.00018739700317382812
▁have 1.01953125
▁shown 3.716796875
▁prom 2.978515625
ising 0.0004189014434814453
▁results 0.64697265625
▁in 0.66943359375
▁impro 3.33203125
ving 4.851818084716797e-05
▁surv 1.5224609375
ival 0.00853729248046875
▁rates 1.1640625
▁for 1.8544921875
▁patients 0.45068359375
▁at 4.30078125
▁different 3.9609375
▁stages 0.10601806640625
▁of 0.15478515625
▁mel 1.5244140625
an 0.00011789798736572266
oma 0.0010232925415039062
. 0.5478515625
▁By 5.74609375
▁expl 4.26171875
oring 9.453296661376953e-05
▁the 0.544921875
▁case 9.7109375
▁of 1.0361328125
▁Mr 4.953125
. 0.1773681640625
▁B 3.28125
, 0.484619140625
▁we 1.396484375
▁can 1.2333984375
▁del 4.69140625
ve 0.002685546875
▁into 0.359375
▁the 0.1649169921875
▁imp 5.3671875
lications 0.00830841064453125
▁of 0.156982421875
▁these 0.69287109375
▁treat 1.7021484375
ments 6.496906280517578e-05
▁and 0.39306640625
▁discuss 3.482421875
▁the 0.93310546875
▁evidence 6.6875
▁supporting 2.107421875
▁their 0.18994140625
▁effic 1.505859375
acy 7.49826431274414e-05
. 0.308349609375
<0x0A> 0.1104736328125
M 2.6015625
el 0.16357421875
an 0.0011348724365234375
oma 0.01358795166015625
▁is 0.2822265625
▁a 0.12286376953125
▁type 0.5791015625
▁of 0.00032806396484375
▁skin 0.228759765625
▁cancer 0.00142669677734375
▁that 0.07269287109375
▁ar 2.7890625
ises 0.00023829936981201172
▁from 0.2069091796875
▁the 0.83203125
▁p 0.82470703125
ig 9.298324584960938e-06
ment 0.00019788742065429688
- 0.058990478515625
produ 0.0170745849609375
cing 4.887580871582031e-06
▁cells 0.0699462890625
, 2.931640625
▁known 0.791015625
▁as 7.87973403930664e-05
▁mel 0.01194000244140625
an 0.0004265308380126953
ocy 0.0001558065414428711
tes 7.37905502319336e-05
. 0.355224609375
▁It 0.8203125
▁is 0.34521484375
▁not 5.953125
orious 1.9931640625
▁for 0.00385284423828125
▁its 0.2445068359375
▁ag 1.1123046875
gress 0.00473785400390625
ive 0.1727294921875
▁nature 0.630859375
▁and 0.42578125
▁potential 1.8583984375
▁to 0.2568359375
▁met 1.896484375
ast 0.00013971328735351562
as 0.000904083251953125
ize 0.02764892578125
. 3.265625
▁However 4.2890625
, 0.0006566047668457031
▁with 0.81884765625
▁the 1.1240234375
▁advent 1.55859375
▁of 0.0005950927734375
▁imm 1.4873046875
une 0.6962890625
▁check 0.0162200927734375
point 0.0016622543334960938
▁in 0.012664794921875
hib 2.384185791015625e-07
itors 0.0296478271484375
, 1.4052734375
▁such 2.22265625
▁as 0.0007319450378417969
▁p 1.6494140625
emb 0.003265380859375
rol 0.00041031837463378906
iz 0.0005140304565429688
um 0.0003647804260253906
ab 7.462501525878906e-05
▁and 0.99462890625
▁n 0.45654296875
iv 0.00027108192443847656
ol 0.0005893707275390625
um 0.0007710456848144531
ab 5.2094459533691406e-05
, 0.0082550048828125
▁remarkable 9.0
▁adv 2.001953125
anc 0.51171875
ements 1.7881393432617188e-05
▁have 0.18212890625
▁been 0.008880615234375
▁made 0.030731201171875
▁in 0.024566650390625
▁the 0.2958984375
▁treatment 0.09271240234375
▁of 0.01580810546875
▁advanced 2.41796875
▁mel 0.34228515625
an 2.6226043701171875e-05
oma 0.01161956787109375
. 0.1419677734375
<0x0A> 1.013671875
Im 3.10546875
m 0.2215576171875
une 0.00211334228515625
▁check 0.04766845703125
point 0.0248870849609375
▁in 0.016510009765625
hib 7.152557373046875e-06
itors 0.006816864013671875
▁work 1.0068359375
▁by 0.010345458984375
▁en 5.12109375
han 0.61767578125
cing 6.556510925292969e-06
▁the 0.050048828125
▁body 1.1728515625
' 1.3251953125
s 6.341934204101562e-05
▁imm 0.184326171875
une 0.0011138916015625
▁response 0.468994140625
▁against 1.63671875
▁cancer 0.399658203125
▁cells 0.1790771484375
. 0.447265625
▁They 1.046875
▁in 4.10546875
hib 0.001529693603515625
it 8.046627044677734e-05
▁the 0.32080078125
▁activity 1.08984375
▁of 0.00016248226165771484
▁prote 3.21484375
ins 4.0531158447265625e-06
▁called 2.994140625
▁imm 1.6904296875
une 0.0030651092529296875
▁check 0.002941131591796875
points 0.10675048828125
, 0.2471923828125
▁which 0.0369873046875
▁restrict 8.1015625
▁the 0.1441650390625
▁imm 0.3408203125
une 0.00015425682067871094
▁system 0.10162353515625
' 0.87109375
s 2.002716064453125e-05
▁ability 0.1783447265625
▁to 5.841255187988281e-05
▁recognize 0.78955078125
▁and 0.01385498046875
▁target 3.134765625
▁cancer 0.09808349609375
▁cells 0.01666259765625
. 0.012664794921875
▁By 0.28125
▁blocking 0.383056640625
▁these 0.050933837890625
▁check 0.490234375
points 0.00731658935546875
, 0.00202178955078125
▁the 0.90478515625
▁imm 0.05670166015625
une 4.172325134277344e-05
▁system 0.004878997802734375
▁is 0.243408203125
▁un 3.353515625
le 0.054962158203125
ashed 7.987022399902344e-05
▁to 0.483154296875
▁attack 0.568359375
▁and 1.2431640625
▁destroy 0.3798828125
▁the 1.708984375
▁tum 2.45703125
or 0.08172607421875
▁cells 1.1171875
. 0.2359619140625
<0x0A> 0.1322021484375
In 1.552734375
▁the 0.82275390625
▁case 0.0938720703125
▁of 0.01197052001953125
▁Mr 0.02105712890625
. 0.0031280517578125
▁B 0.0026912689208984375
, 0.028045654296875
▁a 2.1796875
▁ 0.2144775390625
5 1.3408203125
5 1.71875
- 0.0019273757934570312
year 0.00011909008026123047
- 0.00872039794921875
old 0.00037217140197753906
▁mel 6.84765625
an 0.0001386404037475586
oma 0.00099945068359375
▁patient 0.02880859375
▁diagn 2.93359375
osed 5.733966827392578e-05
▁with 0.1884765625
▁stage 0.81689453125
▁IV 0.8173828125
▁met 2.662109375
ast 0.00014030933380126953
atic 0.01181793212890625
▁mel 0.74658203125
an 0.00010347366333007812
oma 0.0001341104507446289
, 0.18505859375
▁treatment 3.1484375
▁with 0.04620361328125
▁a 3.138671875
▁combination 0.267578125
▁of 0.0201263427734375
▁imm 1.1123046875
une 0.040069580078125
▁check 0.004146575927734375
point 0.0023479461669921875
▁in 0.0052490234375
hib 8.58306884765625e-06
itors 0.01342010498046875
▁led 3.037109375
▁to 0.0006270408630371094
▁a 0.728515625
▁significant 1.810546875
▁improvement 0.67822265625
▁in 0.012420654296875
▁his 0.197265625
▁pro 2.884765625
gn 0.0198211669921875
osis 0.0007905960083007812
. 0.01751708984375
▁Studies 7.62890625
▁have 0.05133056640625
▁shown 0.078369140625
▁that 0.005779266357421875
▁the 0.97265625
▁use 1.6337890625
▁of 0.0001087188720703125
▁p 2.505859375
emb 0.004512786865234375
rol 4.1484832763671875e-05
iz 2.944469451904297e-05
um 0.0001767873764038086
ab 1.049041748046875e-05
▁and 1.0068359375
▁n 0.1441650390625
iv 0.00017511844635009766
ol 0.0002918243408203125
um 8.7738037109375e-05
ab 0.00011801719665527344
▁in 0.64306640625
▁patients 2.91796875
▁with 0.00785064697265625
▁advanced 0.29296875
▁mel 0.056854248046875
an 2.8252601623535156e-05
oma 0.0005249977111816406
▁can 0.45556640625
▁result 1.4296875
▁in 4.076957702636719e-05
▁dur 2.80859375
able 0.0004818439483642578
▁responses 0.60546875
▁and 0.943359375
▁long 2.40234375
- 0.00244140625
term 0.0152130126953125
▁rem 0.4365234375
ission 0.0838623046875
. 0.246337890625
▁In 2.2578125
▁a 2.76171875
▁study 0.880859375
▁by 2.462890625
▁Robert 4.05078125
▁et 1.0078125
▁al 0.00289154052734375
., 0.63916015625
▁the 1.3759765625
▁overall 2.884765625
▁response 0.379150390625
▁rate 0.01038360595703125
▁to 3.125
▁p 1.138671875
emb 0.0102996826171875
rol 5.1140785217285156e-05
iz 2.1338462829589844e-05
um 0.00017011165618896484
ab 3.743171691894531e-05
▁was 1.4541015625
▁ 0.03204345703125
3 1.7822265625
3 2.279296875
%, 0.3876953125
▁with 0.5546875
▁a 0.8505859375
▁median 1.0712890625
▁overall 3.501953125
▁surv 0.04559326171875
ival 1.811981201171875e-05
▁of 0.03912353515625
▁ 0.041473388671875
2 1.01953125
3 2.412109375
▁months 0.744140625
, 3.591796875
▁providing 5.52734375
▁hope 1.763671875
▁for 0.09490966796875
▁patients 0.41650390625
▁like 1.76953125
▁Mr 0.00037860870361328125
. 0.004756927490234375
▁B 0.0014333724975585938
. 0.5283203125
<0x0A> 0.07025146484375
Ad 1.1357421875
j 0.0279388427734375
uv 0.0003223419189453125
ant 0.00028705596923828125
▁ther 0.1849365234375
ap 0.935546875
ies 3.552436828613281e-05
, 1.0380859375
▁which 2.66015625
▁are 0.232421875
▁admin 1.8984375
ister 2.0503997802734375e-05
ed 6.4373016357421875e-06
▁alongside 7.2265625
▁primary 1.82421875
▁treat 1.88671875
ments 2.956390380859375e-05
, 0.572265625
▁have 1.126953125
▁also 0.035003662109375
▁played 4.11328125
▁a 0.1258544921875
▁cru 1.1083984375
cial 7.152557373046875e-07
▁role 0.00024437904357910156
▁in 0.0002498626708984375
▁impro 0.46435546875
ving 3.5762786865234375e-07
▁surv 1.333984375
ival 0.0013704299926757812
▁rates 0.04583740234375
▁in 2.060546875
▁patients 0.78759765625
▁with 0.0194549560546875
▁mel 0.279541015625
an 3.325939178466797e-05
oma 0.0001615285873413086
. 0.006191253662109375
▁In 2.259765625
▁particular 3.009765625
, 0.00010764598846435547
▁target 2.888671875
ed 0.0114898681640625
▁ther 0.05267333984375
ap 0.081298828125
ies 6.0558319091796875e-05
▁and 2.283203125
▁combination 3.8125
▁ther 0.35205078125
ap 0.0263214111328125
ies 8.344650268554688e-07
▁have 0.552734375
▁shown 0.76513671875
▁prom 0.720703125
ising 2.0742416381835938e-05
▁out 3.955078125
comes 4.172325134277344e-06
. 1.376953125
▁Target 1.2998046875
ed 0.002162933349609375
▁ther 0.0023593902587890625
ap 0.0170745849609375
ies 1.5497207641601562e-05
, 1.1455078125
▁such 0.165283203125
▁as 2.2530555725097656e-05
▁B 0.6025390625
RA 0.0124359130859375
F 0.00640869140625
▁and 1.134765625
▁ME 0.050872802734375
K 9.262561798095703e-05
▁in 0.00875091552734375
hib 5.364418029785156e-06
itors 0.0019025802612304688
, 0.009765625
▁specifically 2.4296875
▁target 0.10504150390625
▁the 0.39404296875
▁gen 1.0224609375
etic 0.1376953125
▁mut 0.1673583984375
ations 0.0141754150390625
▁present 2.05078125
▁in 0.0017404556274414062
▁mel 0.323486328125
an 1.049041748046875e-05
oma 0.0265960693359375
▁cells 0.0826416015625
. 1.91015625
▁These 1.8671875
▁in 3.91015625
hib 0.0001342296600341797
itors 0.0048980712890625
▁have 1.955078125
▁been 0.468994140625
▁successful 4.9296875
▁in 0.0031490325927734375
▁patients 6.234375
▁with 0.241455078125
▁B 0.4326171875
RA 0.0017795562744140625
F 0.0002276897430419922
▁gene 4.921875
▁mut 0.0264892578125
ations 0.07269287109375
, 0.431884765625
▁including 5.3125
▁Mr 0.1993408203125
. 0.0016736984252929688
▁B 0.01253509521484375
, 0.62890625
▁leading 2.548828125
▁to 0.0001971721649169922
▁higher 5.671875
▁response 0.4462890625
▁rates 0.0252532958984375
▁and 0.131591796875
▁longer 0.88330078125
▁pro 1.1923828125
gression 0.0011997222900390625
- 0.00112152099609375
free 0.00012767314910888672
▁surv 0.0285797119140625
ival 0.0006632804870605469
. 0.229736328125
<0x0A> 0.2271728515625
F 4.73828125
ur 0.042205810546875
ther 2.2172927856445312e-05
more 0.041748046875
, 2.491474151611328e-05
▁combination 0.57177734375
▁ther 0.01202392578125
ap 0.035247802734375
ies 1.0728836059570312e-06
▁that 3.34375
▁combine 0.9072265625
▁imm 0.9716796875
une 0.267333984375
▁check 0.006256103515625
point 0.005260467529296875
▁in 0.004886627197265625
hib 3.5762786865234375e-07
itors 0.002368927001953125
▁with 0.293212890625
▁target 0.208984375
ed 0.0003864765167236328
▁ther 0.01183319091796875
ap 0.00888824462890625
ies 5.960464477539062e-07
▁have 0.50048828125
▁shown 1.236328125
▁even 1.447265625
▁more 1.63671875
▁impress 1.1767578125
ive 4.291534423828125e-06
▁results 0.1641845703125
. 0.203857421875
▁For 2.142578125
▁instance 1.0947265625
, 5.841255187988281e-05
▁the 0.81640625
▁combination 0.156005859375
▁of 0.0288543701171875
▁d 4.10546875
ab 0.016845703125
raf 0.0002818107604980469
en 0.000690460205078125
ib 2.288818359375e-05
▁and 0.274169921875
▁tram 0.1807861328125
et 0.00031280517578125
in 0.00020515918731689453
ib 0.0004680156707763672
, 0.8564453125
▁B 5.01953125
RA 0.004581451416015625
F 0.0015611648559570312
▁and 0.09893798828125
▁ME 0.00547027587890625
K 0.0001264810562133789
▁in 0.004055023193359375
hib 4.887580871582031e-05
itors 0.0021076202392578125
▁respectively 2.818359375
, 0.00225067138671875
▁with 5.0546875
▁imm 2.986328125
un 3.064453125
other 0.0016145706176757812
apy 0.042694091796875
▁has 1.0458984375
▁demonstrated 2.955078125
▁significant 3.0859375
▁improvements 1.0009765625
▁in 0.005008697509765625
▁overall 0.97802734375
▁response 2.076171875
▁rates 0.91162109375
▁and 0.353515625
▁pro 0.72021484375
gression 0.00021350383758544922
- 0.0015993118286132812
free 0.0004620552062988281
▁surv 0.0014495849609375
ival 4.410743713378906e-05
. 0.94580078125
▁This 2.6328125
▁combination 1.138671875
▁ther 0.56298828125
apy 5.543231964111328e-05
▁has 0.59375
▁been 0.6201171875
▁approved 1.30078125
▁by 0.2174072265625
▁the 0.0063323974609375
▁F 0.243896484375
DA 0.0002644062042236328
▁for 0.26220703125
▁the 0.43408203125
▁treatment 0.1551513671875
▁of 0.00018465518951416016
▁mel 2.587890625
an 1.52587890625e-05
oma 0.002819061279296875
▁patients 2.06640625
▁with 0.185302734375
▁B 0.289306640625
RA 0.00024819374084472656
F 7.104873657226562e-05
▁mut 0.4921875
ations 0.02142333984375
. 0.278076171875
<0x0A> 0.044464111328125
Over 3.640625
all 0.0023651123046875
, 0.0001537799835205078
▁adv 1.68359375
anc 0.12176513671875
ements 4.887580871582031e-06
▁in 0.0010385513305664062
▁mel 2.38671875
an 1.3709068298339844e-05
oma 1.1801719665527344e-05
▁treatment 0.2117919921875
, 2.080078125
▁particularly 0.9111328125
▁the 1.5673828125
▁use 0.05035400390625
▁of 0.00023031234741210938
▁imm 0.03839111328125
une 0.01270294189453125
▁check 0.0006375312805175781
point 0.0015687942504882812
▁in 0.0006203651428222656
hib 7.152557373046875e-07
itors 0.00049591064453125
▁and 0.1116943359375
▁adj 0.1290283203125
uv 0.0010194778442382812
ant 0.00033402442932128906
▁ther 0.0032787322998046875
ap 0.0006685256958007812
ies 1.7881393432617188e-06
, 0.0143890380859375
▁have 0.037353515625
▁significantly 1.4765625
▁increased 4.12109375
▁the 0.2626953125
▁potential 1.3759765625
▁for 0.0029048919677734375
▁long 0.02947998046875
- 0.0007729530334472656
term 0.0009307861328125
▁rem 0.00688934326171875
ission 0.002597808837890625
▁and 0.84765625
▁improved 0.28955078125
▁surv 0.1998291015625
ival 0.00049591064453125
▁rates 0.025177001953125
. 0.63330078125
▁These 2.16015625
▁treat 0.211669921875
ments 2.6226043701171875e-06
▁have 0.4228515625
▁shown 1.923828125
▁prom 0.728515625
ising 1.895427703857422e-05
▁results 0.1561279296875
▁in 0.131103515625
▁patients 0.86767578125
▁at 1.3173828125
▁different 0.082275390625
▁stages 0.0006284713745117188
▁of 0.0191497802734375
▁mel 0.1182861328125
an 3.612041473388672e-05
oma 4.7326087951660156e-05
, 0.1099853515625
▁both 9.4765625
▁in 1.2314453125
▁terms 0.9970703125
▁of 0.0002913475036621094
▁improved 5.796875
▁overall 2.201171875
▁response 0.41796875
▁rates 0.050445556640625
▁and 0.00817108154296875
▁increased 3.048828125
▁overall 2.6015625
▁surv 0.01178741455078125
ival 0.00012886524200439453
. 0.1265869140625
▁The 2.392578125
▁case 0.1397705078125
▁of 0.005420684814453125
▁Mr 0.0006222724914550781
. 0.0011014938354492188
▁B 0.0007495880126953125
▁exempl 3.927734375
ifies 0.0005164146423339844
▁the 0.11334228515625
▁effic 3.009765625
acy 3.814697265625e-06
▁of 0.0225067138671875
▁these 0.08929443359375
▁treat 0.06103515625
ments 4.291534423828125e-06
, 1.3466796875
▁with 3.435546875
▁his 1.4453125
▁favor 6.55078125
able 0.0001068115234375
▁response 0.4931640625
▁to 0.10723876953125
▁imm 1.30859375
une 0.181884765625
▁check 0.00399017333984375
point 0.0013036727905273438
▁in 0.004093170166015625
hib 2.1457672119140625e-06
itors 0.0743408203125
▁and 0.2388916015625
▁target 1.810546875
ed 0.00015819072723388672
▁ther 0.0033283233642578125
ap 0.07318115234375
ies 2.1457672119140625e-06
. 0.6142578125
▁Cont 7.125
in 0.10528564453125
ued 0.0002739429473876953
▁research 0.01776123046875
▁and 0.3310546875
▁adv 2.88671875
anc 0.0374755859375
ements 3.337860107421875e-06
▁in 0.02362060546875
▁this 2.986328125
▁field 0.2236328125
▁offer 4.60546875
▁hope 0.14697265625
▁for 0.023895263671875
▁mel 4.9609375
an 4.76837158203125e-06
oma 8.702278137207031e-06
▁patients 0.0009679794311523438
, 2.029296875
▁as 1.8642578125
▁these 2.96875
▁treat 0.1402587890625
ments 4.172325134277344e-06
▁p 4.66015625
ave 0.00162506103515625
▁the 0.0013408660888671875
▁way 0.00054168701171875
▁for 0.06707763671875
▁better 1.93359375
▁out 0.314697265625
comes 9.167194366455078e-05
▁and 0.2076416015625
▁potentially 4.1875
▁higher 4.9296875
▁c 1.2109375
ure 0.02691650390625
▁rates 0.0004241466522216797
. 0.1573486328125
